Association of IFITM3 with the efficacy of anti-PD1/PD-L1 therapy and regulation of immunosensitivity via MHC-I regulation in SCLC.

Authors: Shengxiang Ren, Yanan Cui, Tianyu Qiu, Jiale Wang, Gaohua Feng, Chunyan Wu, Fengying Wu, Fei Li, Hua Zhang

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.8105

Source: Full article


Abstract

8105